Abstract
Management of inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, is generally cumbersome for patients and is a massive health-economic burden. In recent years, the immunomodulating effects of...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have